SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000950103-18-014700
Filing Date
2018-12-17
Accepted
2018-12-17 16:16:56
Documents
2
Group Members
DR. DENISE SCOTS-KNIGHT

Document Format Files

Seq Description Document Type Size
1 FORM SC 13D dp99673_sc13d.htm SC 13D 87876
2 EXHIBIT 99.1 dp99673_ex9901.htm EX-99.1 5363
  Complete submission text file 0000950103-18-014700.txt   94840
Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Subject) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87757 | Film No.: 181238326
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filed by) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences